Mercury Pharmaceuticals

COVID lockdown babies show language strengths at age four

Research from the BICYCLE study shows 4-year-olds born in lockdown excel in language but face challenges in executive function, indicating a need for support.

Dexamphetamine and methylphenidate work similarly for ADHD but differ in weight effects

A head-to-head trial of ADHD treatments finds dexamphetamine and methylphenidate equally effective, with notable differences in weight management over time.

Diet helps people lose weight regardless of genetic obesity risk

A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging genetic determinism in weight loss.

Leica Biosystems to acquire StatLab

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX platform across India.

BYK strengthens its portfolio of measurement and testing instruments

BYK-Gardner USA, a subsidiary of the specialty chemicals group ALTANA, is acquiring perisens GmbH.

BYK Strengthens its portfolio of measurement and testing instruments through a strategic acquisition in the autonomous driving market

BYK-Gardner USA, a subsidiary of the specialty chemicals group ALTANA, is acquiring perisens GmbH.

Maternal diets high in UPFs may influence children’s health years later

A narrative review of 84 publications links higher ultra-processed food intake during pregnancy and early childhood with poorer diet quality, maternal complications, childhood obesity, and potential immune, metabolic, and neurodevelopmental effects. The authors identify possible microbiome and biopsychosocial pathways but emphasize that the predominantly observational evidence cannot establish causality.

A wife’s account reveals the hidden burden of young-onset Alzheimer’s caregiving

Karina Acton Reid recounts caring for her husband with young-onset Alzheimer’s disease presenting as posterior cortical atrophy while raising two young children. Her perspective shows how visual disorientation, diagnostic delays, changing family roles, and inadequate age-appropriate support affect the entire household.

Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge

Higher baseline plasma p-tau217 was associated with greater 5- and 10-year risks of cognitive impairment and faster cognitive decline among 2,684 cognitively unimpaired adults. Very high levels corresponded to an estimated 38% risk at five years, but selected cohorts and limited long-term data mean routine screening and individualized prediction remain premature.